Pricing Log in Create free account

Aspira Women's Health Inc. (AWHL) vs iSpecimen Inc. (ISPC)

Aspira Women's Health Inc. and iSpecimen Inc. are both Diagnostics & Research companies. Aspira Women's Health Inc. and iSpecimen Inc. are of similar size ($2.6M and $2.4M). Aspira Women's Health Inc. grew revenue faster over the last twelve months: −8.00% against −92.1%. Aspira Women's Health Inc. has the higher net margin (−117.1% vs −2,449.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Aspira Women's Health Inc. leads on 12 and iSpecimen Inc. on 4.

Valuation

Metric AWHL ISPC Diagnostics & Research median
P/E n/m n/m 35.56
P/S 1.19 2.75 4.37
P/B n/m 0.74 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m 0.06 24.35
EV/Sales 1.36 (1.11) 5.51
Earnings yield (106.09%) (6,134.78%) (1.89%)
Free cash flow yield (46.46%) (846.31%) (0.15%)

Profitability

Metric AWHL ISPC Diagnostics & Research median
Gross margin 58.78% (108.26%) 50.89%
Operating margin (80.75%) (2,020.05%) (8.57%)
Net margin (117.07%) (2,449.02%) (6.37%)
Free cash flow margin (55.32%) (1,866.61%) 0.00%
Return on equity 201.29% (968.44%) (2.92%)
Return on assets (213.58%) (170.09%) (6.71%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AWHL ISPC Diagnostics & Research median
Revenue growth (TTM) (8.00%) (92.11%) 7.69%
EPS growth (last fiscal year) 60.22% 87.03% 25.92%
Revenue growth, 5-year CAGR 14.66% (25.10%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AWHL ISPC Diagnostics & Research median
Debt to equity (0.27) 0.00 0.11
Current ratio 0.52 0.82 2.02
Net debt to EBITDA 0.00 0.95 0.70

Dividend

Metric AWHL ISPC Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric AWHL ISPC Diagnostics & Research median
Market cap 2.44m 2.60m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack